SFRI is a full service Diversity Contract Research Site specializing in Proof of Concept as well as Phase I through IV studies in infection, GI, women’s health, allergy, asthma, ocular,oncology and dermatology utilizing innovative clinical research site and remote processes . SFRI conducts single and multi-center studies and field studies. We have conducted multiple interventional as well as non-interventional drug studies sponsored by the industry as well as the government.
We are one of the sites currently conducting a clinical trial with Regeneron to better understand the efficacy of REGN-COV2 in treating mild to moderate cases of Covid-19. It has already been approved by the FDA for emergency use and is one of the drugs that Mr. Trump received. This study is in Phase III of research and we are actively enrolling eligible participants.
- We are looking for patients that tested positive for COVID-19 in the past 3-7 days.
- The compensation for participation is $3,650 (participants receive half at day 15 of treatment and the rest at day 30).
Email us with questions at firstname.lastname@example.orgCheck Eligibility
SFRI has years of expertise in Dietary supplement trials and has worked with the leading supplement companies in the world. We cater out services per your requirements. We offer a range of services, right from protocol development to statistical analysis and claim substantiation by peer reviewed articles.download brochure
Beauty and Cosmetics
SFRI will work with you to verify the safety and quality of your raw materials. We offer a full spectrum of regulatory, scientific, and testing solutions. We have the expertise and in-house capabilities to perform an array of cosmetic testing utililizing high quality instruments and high-tech softwares. Additionally we provide consultation to understand which tests are required from a regulatory point of view after assessing all desired markets.Download brochure
Access the highest quality human biological materials. SFRI helps facilitate breakthroughs in genetics, drug discovery, biomarker research, and molecular diagnostics by supplying high quality human biospecimens to leading bio-banking companies.download brochure
San Francisco Research Institute understands your need to move your product through the development pipeline expediently. The Phase I – IV clinical trials done at our institute are completed in a timely manner. We work closely with sponsors and CROs to insure the best quality of clinical research.